GlassScriptPhysician profile
Boris Cehajic
NPI 1710321211
$20,744.08
in general payments reported to CMS, 2019-2025
26 companies · $444 in 2025
The $444 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $1,512 · 2021: $233 · 2022: $368 · 2023: $467 · 2024: $457 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,368.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $18,755.94 | 2019-2025 | |
| Davol INC. | $321.13 | 2019-2024 | Phasix Mesh |
| Abbvie INC. | $320.18 | 2023-2025 | Strattice Reconstructive Tissue Matrix Bps |
| Ethicon US, LLC | $299.72 | 2021-2025 | Vistaseal, Echelon Flex, Harmonic |
| Merck Sharp & Dohme LLC | $194.90 | 2020-2024 | Bridion |
| Takeda Pharmaceuticals U.S.A., INC. | $131.27 | 2020-2024 | Gattex |
| Kerecis Limited | $130.28 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Hologic Sales and Service, LLC | $121.20 | 2023-2024 | Localizer, Biozorb, Coolseal Generator |
| Allergan, INC. | $86.55 | 2022 | |
| Shire North American Group INC | $44.54 | 2019 | |
| Myriad Genetic Laboratories, INC. | $38.97 | 2023-2025 | Myrisk |
| Mallinckrodt Enterprises LLC | $38.22 | 2019 | |
| Integra Lifesciences Corporation | $30.68 | 2020-2022 | |
| Convatec INC. | $26.15 | 2025 | |
| Eagle Pharmaceuticals, INC. | $25.20 | 2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $23.46 | 2020 | |
| Teleflex LLC | $20.21 | 2021 | |
| Csl Behring | $19.65 | 2019 | |
| Smith+Nephew, INC. | $18.59 | 2024 | Allevyn Life L 15.4x15.4 Ctn10, Tc-100, Acticoat 4" X 4" |
| Bard Peripheral Vascular, INC. | $17.69 | 2021 | |
| Lemaitre Vascular, INC. | $14.84 | 2022 | |
| Innocoll Pharmaceuticals Limited | $14.73 | 2022 | |
| Acera Surgical, INC. | $13.88 | 2019 | |
| Tela Bio, INC. | $12.72 | 2019 | |
| Covidien LP | $12.01 | 2019 | |
| Conmed Corporation | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Cehajic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.